anti-FAP single-chain-antibody fragments (Boehringer Ingelheim/Stuttgart University)

N/A

Report date: 2025/03/17 20:00:36

Base Information

Drug Nameanti-FAP single-chain-antibody fragments (Boehringer Ingelheim/Stuttgart University)
Drug Alias NameF19 derivatives (Boehringer Ingelheim/Stuttgart University)2nd generation BIBH-1 (Boehringer Ingelheim/Stuttgart University)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionBlood coagulation stimulants
TargetsUpdating
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Stuttgart
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of StuttgartBoehringer Ingelheim International Gmbh
Active IndicationsN/A
Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A
Related LinksN/A